Skip to Content
MilliporeSigma
All Photos(1)

Documents

PHR1472

Supelco

Tartaric Acid

Pharmaceutical Secondary Standard; Certified Reference Material

Synonym(s):

L-(+)-Tartaric acid, (2R,3R)-(+)-Tartaric acid, L-Threaric acid

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
HO2CCH(OH)CH(OH)CO2H
CAS Number:
Molecular Weight:
150.09
Beilstein/REAXYS Number:
1725147
EC Number:
MDL number:
UNSPSC Code:
41116107
PubChem Substance ID:
NACRES:
NA.24

grade

certified reference material
pharmaceutical secondary standard

Quality Level

agency

traceable to USP 1643340

vapor density

5.18 (vs air)

API family

tartaric acid

CofA

current certificate can be downloaded

autoignition temp.

797 °F

packaging

pkg of 1 g

technique(s)

HPLC: suitable
gas chromatography (GC): suitable

mp

170-172 °C (lit.)

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-30°C

SMILES string

O[C@H]([C@@H](O)C(O)=O)C(O)=O

InChI

1S/C4H6O6/c5-1(3(7)8)2(6)4(9)10/h1-2,5-6H,(H,7,8)(H,9,10)/t1-,2-/m1/s1

InChI key

FEWJPZIEWOKRBE-JCYAYHJZSA-N

Looking for similar products? Visit Product Comparison Guide

General description

Certified pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to pharmacopeia primary standards
Tartaric Acid belongs to the group of carboxylic acids, and is abundantly found in grapes and wine. It is widely used in drugs, food, and beverage industry.

Application

Tartaric Acid may be used as a pharmaceutical reference standard for the quantification of the analyte in pharmaceutical formulations using stopped-flow chemiluminescence spectrometry.
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.

Analysis Note

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

Other Notes

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

Footnote

To see an example of a Certificate of Analysis for this material enter LRAC1695 in the slot below. This is an example certificate only and may not be the lot that you receive.

Recommended products

Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.

related product

pictograms

Corrosion

signalword

Danger

hcodes

Hazard Classifications

Eye Dam. 1

wgk_germany

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Sensitive determination of periodate and tartaric acid by stopped-flow chemiluminescence spectrometry
Gaikwad A, et al.
Analyst, 119(8), 1819-1824 (1994)
Sho Isoyama et al.
Cancer science, 106(2), 171-178 (2014-12-09)
Drug resistance often critically limits the efficacy of molecular targeted drugs. Although pharmacological inhibition of phosphatidylinositol 3-kinase (PI3K) is an attractive therapeutic strategy for cancer therapy, molecular determinants for efficacy of PI3K inhibitors (PI3Kis) remain unclear. We previously identified that
Enological Chemistry, 4(8), 1819-1824 (2012)
Encyclopaedia of Occupational Health and Safety: Industries and Occupations, 4(8), 1819-1824 (1998)
Miyako Yoshida et al.
Chemical & pharmaceutical bulletin, 62(12), 1252-1258 (2014-12-03)
The objective of this study was to evaluate an improved bitterness sensor which has been developed to allow the precise and sensitive prediction of the bitterness of acidic bitter pharmaceutical active ingredients, using as examples nine non-steroidal anti-inflammatory drugs (NSAIDs).

Protocols

Science Slam panel: Leading gene therapy developers discuss commercialization challenges and the importance of robust process development plans.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service